ArticleRSC advances2018

miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway.

Yingping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.